deltatrials
Completed NA INTERVENTIONAL 2-arm NCT02589392

Cetaphil Restoraderm Effect on Young Children With Atopic Dermatitis

Effect of Cetaphil® Restoraderm® Moisturizer on Very Dry Skin in Children With a Controlled Atopic Dermatitis:a Randomised, Parallel Group Study

Sponsor: Galderma R&D

Updated 8 times since 2017 Last updated: Feb 12, 2024 Started: May 29, 2015 Primary completion: Feb 3, 2016 Completion: Feb 3, 2016
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02589392, this NA trial focuses on Atopic Dermatitis and remains completed. Sponsored by Galderma R&D, it has been updated 8 times since 2015, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

~Jan 2017 – ~Jun 2018 · 17 months · monthly snapshotCompleted~Jun 2018 – ~Jan 2021 · 31 months · monthly snapshotCompleted~Jan 2021 – ~Oct 2021 · 9 months · monthly snapshotCompleted~Oct 2021 – ~Mar 2024 · 29 months · monthly snapshotCompleted~Mar 2024 – ~Jul 2024 · 4 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshotCompleted~Sep 2025 – present · 10 months · monthly snapshotCompleted

Change History

8 versions recorded
  1. Sep 2025 — Present [monthly]

    Completed NA

  2. Sep 2024 — Sep 2025 [monthly]

    Completed NA

  3. Jul 2024 — Sep 2024 [monthly]

    Completed NA

  4. Mar 2024 — Jul 2024 [monthly]

    Completed NA

    Phase: PHASE4NA

  5. Oct 2021 — Mar 2024 [monthly]

    Completed PHASE4

Show 3 earlier versions
  1. Jan 2021 — Oct 2021 [monthly]

    Completed PHASE4

  2. Jun 2018 — Jan 2021 [monthly]

    Completed PHASE4

  3. Jan 2017 — Jun 2018 [monthly]

    Completed PHASE4

    First recorded

May 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Galderma R&D
Data source: Galderma R&D

For direct contact, visit the study record on ClinicalTrials.gov .